Valuation HBM Healthcare Investments AG
Equities
HBMN
CH0012627250
Investment Management & Fund Operators
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 219.00 CHF | +3.06% |
|
+6.31% | +24.43% |
| Dec. 08 | HBM Healthcare Investments Set to Receive Payments from Portfolio Company Sale | MT |
| Dec. 08 | Mirum Pharmaceuticals to acquire HBM portfolio company Bluejay Therapeutics | RE |
Company Valuation: HBM Healthcare Investments AG
Data adjusted to current consolidation scope
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 2,313 | 1,920 | 1,489 | 1,338 | 1,226 | 1,463 | - | - |
| Change | - | -16.99% | -22.46% | -10.13% | -8.4% | 19.36% | - | - |
| Enterprise Value (EV) 1 | 2,409 | 2,064 | 1,632 | 1,427 | 1,323 | 1,461 | 1,443 | 1,339 |
| Change | - | -14.35% | -20.91% | -12.56% | -7.32% | 10.45% | -1.23% | -7.21% |
| P/E ratio | 3.06x | -24.6x | -10.2x | -2,766x | 66.3x | 180x | 13.7x | 12.9x |
| PBR | 1.08x | 0.97x | 0.84x | 0.78x | 0.74x | 0.91x | 0.88x | 0.85x |
| PEG | - | 0x | -0.1x | 27.8x | -0x | -3.3x | 0x | 1.93x |
| Capitalization / Revenue | - | -51.2x | -12.8x | 56.2x | 29.3x | 41.7x | 10.9x | 10.3x |
| EV / Revenue | - | -55x | -14x | 60x | 31.6x | 41.6x | 10.7x | 9.46x |
| EV / EBITDA | 3.18x | -27.4x | -11.2x | -554x | 83.8x | 143x | 13.2x | 11.5x |
| EV / EBIT | 3.18x | -27.4x | -11.2x | -554x | 83.8x | 143x | 13.2x | 11.5x |
| EV / FCF | 43.2x | -34.3x | 18.3x | 15.4x | 178x | 22.4x | 20.6x | 8.63x |
| FCF Yield | 2.31% | -2.92% | 5.46% | 6.51% | 0.56% | 4.46% | 4.86% | 11.6% |
| Dividend per Share 2 | 12.5 | 9.7 | 7.5 | 7.5 | 7.5 | 7.63 | 7.38 | 7.38 |
| Rate of return | 3.76% | 3.51% | 3.5% | 3.87% | 4.14% | 3.48% | 3.37% | 3.37% |
| EPS 2 | 108.7 | -11.22 | -20.98 | -0.07 | 2.73 | 1.22 | 15.97 | 17.04 |
| Distribution rate | 11.5% | -86.5% | -35.7% | -10,714% | 275% | 625% | 46.2% | 43.3% |
| Net sales 1 | - | -37.5 | -116.5 | 23.79 | 41.9 | 35.1 | 134.4 | 141.6 |
| EBITDA 1 | 758.7 | -75.31 | -146.1 | -2.574 | 15.78 | 10.2 | 109.5 | 116.7 |
| EBIT 1 | 758.7 | -75.31 | -146.1 | -2.574 | 15.78 | 10.2 | 109.5 | 116.7 |
| Net income 1 | 756.3 | -78.03 | -145.3 | -0.487 | 18.43 | 10.2 | 109.5 | 116.7 |
| Net Debt 1 | 96.21 | 143.5 | 143.5 | 89.16 | 97.09 | -2 | -20 | -124 |
| Reference price 2 | 332.50 | 276.00 | 214.00 | 193.60 | 181.00 | 219.00 | 219.00 | 219.00 |
| Nbr of stocks (in thousands) | 6,957 | 6,957 | 6,957 | 6,911 | 6,772 | 6,680 | - | - |
| Announcement Date | 5/27/21 | 5/18/22 | 5/26/23 | 5/8/24 | 5/14/25 | - | - | - |
1CHF in Million2CHF
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 174.18x | 40.39x | 138.98x | 3.59% | 1.79B | |
| 10.11x | - | - | 8.47% | 3.39B | |
| 10.08x | 6.28x | 8.85x | -.--% | 1.14B | |
| 13.7x | - | - | 14.33% | 519M | |
| Average | 52.02x | 23.34x | 73.91x | 6.6% | 1.71B | |
| Weighted average by Cap. | 53.29x | 27.13x | 88.39x | 6.23% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- HBMN Stock
- Valuation HBM Healthcare Investments AG
Select your edition
All financial news and data tailored to specific country editions
